logo
  • Home
  • News
Menu

Here’s Why FibroGen Stock Is Plunging Today

Home / Stock Analysis / Here’s Why FibroGen Stock Is Plunging Today
Article feature image

Here’s Why FibroGen Stock Is Plunging Today

16 Jul Stock Analysis

What happened
FibroGen(NASDAQ:FGEN) stock imploded Friday after an FDA advisory panel voted Thursday against approving the company’s lead drug candidate, roxadustat. Shares of the biotech were down by around 46% as of 1:20 p.m. EDT.
So what 
The FDA convened…

Click here to view the original article.

Tags:
Global, Motley Fool
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1756256221620.jpeg
+

Marathon Petroleum (MPC): Assessing Valuation Following Recent Share Price Pullback

11 Oct Stock Analysis
1585186655182.jpeg
+

A Fresh Look at Gorman-Rupp’s (GRC) Valuation After Recent Share Price Momentum

11 Oct Stock Analysis

recent post

  • 1756256221620.jpeg

    Marathon Petroleum (MPC): Assessing Valuation Following

    Oct 11 2025
  • hackers.jpg

    Another Crypto Data Leak Underscores Industry’s

    Oct 11 2025
  • 1585186655182.jpeg

    A Fresh Look at Gorman-Rupp’s (GRC)

    Oct 11 2025
  • featured_image-649.png

    BTCUSD News Today: Crypto Market Crash

    Oct 11 2025
  • 1585186663126.jpeg

    Cavco Industries (CVCO): Exploring Valuation After

    Oct 11 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.